__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Beovu is indicated in adults for the treatment of neovascular (wet) AMD.1
AMD, age-related macular degeneration.
Reference
- Beovu Summary of Product Characteristics, 2020.
About the molecule and how it works.Show more
Visual acuity outcomes with Beovu in clinical trials.Show more
Anatomical outcomes with Beovu in clinical trials.Show more
Treatment interval outcomes with Beovu in clinical trials.Show more
Downloadable summaries of the HAWK and HARRIER Phase III clinical trials.Show more